Shares of hVIVO plc (LON:HVO – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 28.04 ($0.35) and traded as high as GBX 28.50 ($0.35). hVIVO shares last traded at GBX 27.20 ($0.34), with a volume of 1,771,474 shares trading hands.
hVIVO Stock Performance
The stock has a market capitalization of £183.77 million, a PE ratio of -1.00 and a beta of 0.99. The company has a debt-to-equity ratio of 9.83, a quick ratio of 1.16 and a current ratio of 1.46. The firm’s 50 day moving average is GBX 27.94 and its two-hundred day moving average is GBX 24.25.
hVIVO Cuts Dividend
The business also recently declared a dividend, which will be paid on Monday, May 20th. Shareholders of record on Thursday, April 18th will be given a GBX 0.20 ($0.00) dividend. This represents a yield of 0.68%. The ex-dividend date of this dividend is Thursday, April 18th.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- Election Stocks: How Elections Affect the Stock Market
- Comprehensive PepsiCo Stock Analysis
- How to Use Stock Screeners to Find Stocks
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- The Significance of Brokerage Rankings in Stock Selection
- Bear Market Funds to Watch This Year
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.